Dongchen (Daisy) Li

Dongchen (Daisy) Li has worked in the biopharmaceutical industry for the past nine years. In 2012, they began their career as a Research Assistantin at the University of Zurich. In 2014, they were an Assistant to the Chief Scientific Officer at Prosperous Biopharm and a Consultant to Biologics Testing Solutions of Charles River Laboratories at Beijing Prosperous Biopharm Co., Ltd. Li then moved to Innovent Biologics, Inc. (信德生物制药有限公司) as a Business Development professional in 2015. In 2017, they became the Director of Business Development at Gmax Biopharm. Most recently, in 2019, they took on the same role at 广州冷藻生物医药有限公司. Currently, they are the Director of Business Development at Starna Therapeutics.

Dongchen (Daisy) Li has a diverse educational background. Dongchen (Daisy) obtained their Bachelor's Degree in Pharmaceutical Engineering from Southeast University in 2007. Dongchen (Daisy) then attended ETH Zürich from 2007 to 2009, studying Medicinal and Industrial Pharmaceutical Sciences. Finally, they earned their Master's Degree in Human Biology from the University of Zurich in 2012.